Your browser doesn't support javascript.
loading
Previous intravenous chemotherapy does not alter response rate or survival time of patients with hepatic metastases from colorectal cancer treated by hepatic artery chemotherapy.
Morris, D L; Zhao, J; Clingan, P R.
Afiliación
  • Morris DL; University of New South Wales Department of Surgery, St. George Hospital, Kogarah, Australia.
Aust N Z J Surg ; 67(11): 796-7, 1997 Nov.
Article en En | MEDLINE | ID: mdl-9396998
ABSTRACT

BACKGROUND:

The present paper addressed the issue of whether pretreatment with intravenous (i.v.) chemotherapy affects response rate or survival in patients receiving hepatic artery chemotherapy (HAC).

METHODS:

Case note reviews of 164 patients treated in a teaching hospital from June 1990 to July 1996 were carried out.

RESULTS:

The response rate and carcino-embryonic antigen (CEA) fall in the two groups was almost identical. There was a nonsignificant survival advantage in the non-pretreatment group.

CONCLUSIONS:

Previous administration of i.v. chemotherapy did not affect the CEA response of patients receiving HAC.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infusiones Intraarteriales / Neoplasias Colorrectales / Fluorouracilo / Arteria Hepática / Neoplasias Hepáticas / Antimetabolitos Antineoplásicos Límite: Humans Idioma: En Revista: Aust N Z J Surg Año: 1997 Tipo del documento: Article País de afiliación: Australia
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infusiones Intraarteriales / Neoplasias Colorrectales / Fluorouracilo / Arteria Hepática / Neoplasias Hepáticas / Antimetabolitos Antineoplásicos Límite: Humans Idioma: En Revista: Aust N Z J Surg Año: 1997 Tipo del documento: Article País de afiliación: Australia